Literature DB >> 9843803

Independent inhibition of calcineurin and K+ currents by the immunosuppressant FK-506 in rat ventricle.

W H duBell1, S T Gaa, W J Lederer, T B Rogers.   

Abstract

FK-506 increases the cytosolic Ca2+ concentration transient in rat ventricular myocytes by prolonging the action potential through inhibition of the K+ currents Ito and IK [J. Physiol. (Lond.) 501: 509-516, 1997]. Physiological and biochemical techniques were used in parallel to examine the electrophysiological mechanisms and the role of calcineurin inhibition in these effects. FK-506 prolonged the recovery of Ito from inactivation. Thus Ito inhibition was frequency dependent, with no decrease at 0.2 Hz (recorded at +50 mV from -70 mV) but a 40% decrease at 2.0 Hz. In contrast, inhibition of IK ( approximately 60%) was time and voltage independent. At 25 microM, FK-506 (by 65%) and cyclosporin A (by 57%) inhibited calcineurin activity in myocyte extracts. However, only FK-506 increased the cytosolic Ca2+ concentration transient in field-stimulated myocytes. Furthermore, FK-506 was still active on K+ currents when cells were dialyzed with 10 mM EGTA. These results demonstrate that calcineurin inhibition is not responsible for the functional effects of FK-506 in heart and suggest that IK and Ito are modulated by FK-506-binding proteins or directly by FK-506.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843803     DOI: 10.1152/ajpheart.1998.275.6.H2041

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Calcineurin inhibition and cardiac hypertrophy: a matter of balance.

Authors:  L A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Termination of cardiac Ca(2+) sparks: an investigative mathematical model of calcium-induced calcium release.

Authors:  Eric A Sobie; Keith W Dilly; Jader dos Santos Cruz; W Jonathan Lederer; M Saleet Jafri
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

3.  Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.

Authors:  L J De Windt; H W Lim; O F Bueno; Q Liang; U Delling; J C Braz; B J Glascock; T F Kimball; F del Monte; R J Hajjar; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect.

Authors:  T Minematsu; H Ohtani; Y Yamada; Y Sawada; H Sato; T Iga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-12       Impact factor: 2.745

5.  Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth.

Authors:  A L Serrano; M Murgia; G Pallafacchina; E Calabria; P Coniglio; T Lømo; S Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells.

Authors:  László Szabó; Norbert Szentandrássy; Kornél Kistamás; Bence Hegyi; Ferenc Ruzsnavszky; Krisztina Váczi; Balázs Horváth; János Magyar; Tamás Bányász; Balázs Pál; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-19       Impact factor: 3.000

7.  Calmodulin mediates differential sensitivity of CaMKII and calcineurin to local Ca2+ in cardiac myocytes.

Authors:  Jeffrey J Saucerman; Donald M Bers
Journal:  Biophys J       Date:  2008-08-08       Impact factor: 4.033

8.  Functional coupling of calcineurin and protein kinase A in mouse ventricular myocytes.

Authors:  L F Santana; E G Chase; V S Votaw; Mark T Nelson; R Greven
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

9.  Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.

Authors:  Yonggang Liu; F Steven Korte; Farid Moussavi-Harami; Man Yu; Maria Razumova; Michael Regnier; Michael T Chin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

Review 10.  Cardiovascular effects of immunosuppression agents.

Authors:  Aly Elezaby; Ryan Dexheimer; Karim Sallam
Journal:  Front Cardiovasc Med       Date:  2022-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.